Increased Risk of Bladder Cancer Subsequent to Hysterectomy: A Nationwide Cohort Study

Lee J1, Choi J1, Lee H2, Lee D2, Min G2, Lee D3, Ahn S3, Chung K4

Research Type

Clinical

Abstract Category

Prevention and Public Health

Abstract 72
Prevention and public health
Scientific Podium Short Oral Session 8
Wednesday 23rd October 2024
14:07 - 14:15
Hall N106
Pathophysiology Pelvic Floor Prevention Surgery
1. Nowon Eulji University Hospital, 2. Kyung Hee University Hospital, 3. Hanil General Hospital, 4. Gachon University Hospital
Presenter
Links

Abstract

Hypothesis / aims of study
We evaluated the relationship between previous hysterectomy for uterine fibroids and subsequent development of urinary tract cancers.
Study design, materials and methods
South Korea offers public health insurance for all Koreans. Consequently, Korea's National Health Insurance Service can access the medical records (sex, age, surgery name, prescription drug name, diagnosis name, type of medical insurance, hospitalization, and outpatient treatment) of most Koreans (approximately 51 million people). The Health Insurance Review and Assessment Service is a nationwide organization that arbitrates health insurance payment disputes between the NHIS and medical institutions. Therefore, the HIRA has access to most of the National Health Insurance Corporation's medical record information for Koreans. This population-based retrospective cohort utilized HIRA's health insurance data study (January 1, 2007, to December 31, 2020).
 The International Classification of Diseases, 10th Revision (ICD-10) and Korea Health Insurance Medical Care Expenses (2016, 2019 edition) were utilized for the analyses in this study. In this study, the hysterectomy group consisted of women aged 40 to 59 who underwent hysterectomy for uterine leiomyoma or adenomyosis between January 1, 2011, and December 31, 2014. The day of the hysterectomy was designated as the inclusion date. The control group consisted of women aged 40 to 59 who visited a medical facility for a checkup between January 1, 2011 and December 31, 2014. Those who had a hysterectomy were not included in the control group. The inclusion day was designated as the date of the initial health examination visit. In all groups, patients with any cancer (any Cxx) were excluded before the 180th day of inclusion. For the selected hysterectomy group and control group, 1:1 propensity score matching was performed for age in 5-year intervals, year of inclusion, socioeconomic status (SES), parity, region, Charlson comorbidity index (CCI), adnexal surgery before inclusion, menopause before inclusion, menopausal hormone therapy, and pelvic organ prolapse before inclusion.
 Information about the bladder, ureter, and kidney cancer diagnoses was derived from the Korean Cancer Register using ICD-7 nomenclature.
Results
After matching, 7,573 cases (hysterectomy group) and 7,573 controls (nonhysterectomy group) were enrolled. The mean follow-up period was 11.6 years in the controls and 11.8 years in the cases. Compared to the rate in the controls, prior hysterectomy for uterine fibroids significantly increased the rate of subsequent bladder cancer (HR (95% CI): 8.000 (1.001-63.960), p=0.049). However, the risk of kidney cancer (HR (95% CI): 1.286 (0.479-3.452), p=0.618) and ureter cancer (HR (95% CI): 0.500 (0.045-5.514), p=0.571) was not significantly increased after hysterectomy for uterine fibroids as compared to controls.
Interpretation of results
Hysterectomy for uterine fibroids significantly increased bladder cancer  in Korea National Health Insurance Data.
Concluding message
Patients who plan to undergo hysterectomy for the treatment of uterine fibroids should be counseled about the risk of bladder cancer.
Disclosures
Funding None Clinical Trial No Subjects Human Ethics Committee Sangye Paick Hospital Helsinki Yes Informed Consent Yes
Citation

Continence 12S (2024) 101414
DOI: 10.1016/j.cont.2024.101414

13/11/2024 19:31:36